"There's been a lot of talk about moving next-generation sequencing into clinical diagnostic settings," Stephen Kingsmore told BioWorld Today. Last week, Kingsmore and a team of colleagues reported a big step in that direction: the development of a carrier test that screens for about 450 rare recessive disorders and could be used on either parents or infants.